Maximus (NYSE:MMS) Director Sells $53,609.50 in Stock

March 18, 2026 by InsiderTrades.com

Key Points

Director Jan Madsen sold 742 shares on March 17 at an average of $72.25 for a total of $53,609.50, trimming his stake by 3.45% to 20,795 shares (≈$1.50M).
Maximus reported quarterly EPS of $1.85 (beat by $0.01) while revenue fell 4.1% year‑over‑year; the company set FY2026 guidance of 8.050–8.350 EPS and the stock trades near $72, below its 50‑ and 200‑day moving averages (~$83.80 and $85.44).
The board increased the quarterly dividend to $0.33 (annualized $1.32, yield ~1.8% and a 20.1% payout ratio), and about 97.2% of shares are held by institutional investors.

Maximus, Inc. (NYSE:MMS - Get Free Report) Director Jan Madsen sold 742 shares of Maximus stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Maximus Stock Performance

NYSE MMS opened at $72.11 on Wednesday. The business has a 50-day moving average price of $83.80 and a 200-day moving average price of $85.44. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a twelve month low of $64.68 and a twelve month high of $100.00. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 10.98 and a beta of 0.59.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the firm posted $1.61 EPS. The company's revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, February 13th. This is a boost from Maximus's previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. Maximus's dividend payout ratio is currently 20.09%.

Institutional Investors Weigh In On Maximus

A number of large investors have recently made changes to their positions in the stock. Richardson Financial Services Inc. boosted its stake in shares of Maximus by 29.6% in the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider's stock worth $39,000 after buying an additional 103 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock valued at $25,000 after buying an additional 116 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Maximus by 13.4% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider's stock valued at $109,000 after purchasing an additional 150 shares during the period. Arizona State Retirement System boosted its holdings in Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider's stock worth $1,524,000 after buying an additional 156 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider's stock worth $122,000 after acquiring an additional 163 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on MMS shares. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Monday, February 23rd. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, December 30th. Finally, Weiss Ratings cut Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research note on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Buy".

Read Our Latest Stock Report on Maximus

Maximus Company Profile

(Get Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.